<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Ji M</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic platelet accumulation has been reported during the progression of PA-induced liver injury (PA-ILI). This study aimed to investigate the mechanisms underlying platelet accumulation in PA-ILI.&lt;h4>Methods&lt;/h4>Cases of PA-ILI, non-PA-ILI, and control subjects were collected from patients hospitalized at Zhongshan Hospital, Fudan University (Shanghai, China) between 2012 and 2019. A mouse model of PA-ILI was established using monocrotaline administration. Liver RNA sequencing was performed, and gene interactions were analyzed using the Search Tool for the Retrieval of Interacting Genes/Proteins online database. Low-molecular-weight heparin and recombinant a disinte</pubmed_abstract><journal>Journal of clinical and translational hepatology</journal><pagination>25-34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11712092</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ADAMTS13 Improves Hepatic Platelet Accumulation in Pyrrolizidine Alkaloids-induced Liver Injury.</pubmed_title><pmcid>PMC11712092</pmcid><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Ren J</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Zeng X</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Ji M</pubmed_authors></additional><is_claimable>false</is_claimable><name>ADAMTS13 Improves Hepatic Platelet Accumulation in Pyrrolizidine Alkaloids-induced Liver Injury.</name><description>&lt;h4>Background and aims&lt;/h4>Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic platelet accumulation has been reported during the progression of PA-induced liver injury (PA-ILI). This study aimed to investigate the mechanisms underlying platelet accumulation in PA-ILI.&lt;h4>Methods&lt;/h4>Cases of PA-ILI, non-PA-ILI, and control subjects were collected from patients hospitalized at Zhongshan Hospital, Fudan University (Shanghai, China) between 2012 and 2019. A mouse model of PA-ILI was established using monocrotaline administration. Liver RNA sequencing was performed, and gene interactions were analyzed using the Search Tool for the Retrieval of Interacting Genes/Proteins online database. Low-molecular-weight heparin and recombinant a disinte</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-07-15T08:50:12.839Z</modification><creation>2026-07-03T03:10:32.041Z</creation></dates><accession>S-EPMC11712092</accession><cross_references><pubmed>39801786</pubmed><doi>10.14218/JCTH.2024.00233</doi></cross_references></HashMap>